Cardinal Health Reports Q4 Revenue of $60.2 Billion, Raises FY2026 Guidance
PorAinvest
martes, 12 de agosto de 2025, 3:43 pm ET1 min de lectura
CAH--
Cardinal Health's CEO, Jason Hollar, highlighted the company's operational strength, stating, "Fiscal 2025 was a transformative year for Cardinal Health, and we closed the year with momentum, delivering strong fourth quarter results" [1].
The company also announced that it has raised its FY2026 non-GAAP EPS guidance to $9.30-$9.50, a 13-15% increase from the previous guidance of $9.10-$9.30. This increase reflects a benefit to net earnings from classifying the shares held by physicians and management of The Specialty Alliance as a liability and increased contributions from the Pharmaceutical and Specialty Solutions segment and the growth businesses reported in Other [1].
Additionally, Cardinal Health plans to repurchase $750 million worth of shares and expects to spend approximately $600 million on capital expenditures during FY2026. The company also expects non-GAAP adjusted free cash flow to be between $2.75 billion and $3.25 billion for the year [1].
References:
[1] https://newsroom.cardinalhealth.com/2025-08-12-Cardinal-Health-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Results-and-Raises-Fiscal-Year-2026-Guidance
Cardinal Health reported Q4 non-GAAP operating earnings of $719 million, a 19% increase, and non-GAAP EPS of $2.08. FY2025 revenue was $222.6 billion, a 2% decrease, but non-GAAP operating earnings rose 15% to $2.8 billion. The company raised FY2026 non-GAAP EPS guidance to $9.30-$9.50, a 13-15% increase, and plans to repurchase $750 million worth of shares.
Cardinal Health (NYSE: CAH) reported its fourth quarter (Q4) and fiscal year 2025 (FY25) results, showing a relatively flat revenue of $60.2 billion for the quarter and a 2% decrease in FY25 revenue to $222.6 billion compared to the previous year. Despite the revenue changes, the company's non-GAAP operating earnings increased significantly. Q4 non-GAAP operating earnings were $719 million, a 19% increase, while non-GAAP EPS was $2.08, a 13% increase. For the full year, non-GAAP operating earnings rose 15% to $2.8 billion, with non-GAAP EPS increasing 9% to $8.24 [1].Cardinal Health's CEO, Jason Hollar, highlighted the company's operational strength, stating, "Fiscal 2025 was a transformative year for Cardinal Health, and we closed the year with momentum, delivering strong fourth quarter results" [1].
The company also announced that it has raised its FY2026 non-GAAP EPS guidance to $9.30-$9.50, a 13-15% increase from the previous guidance of $9.10-$9.30. This increase reflects a benefit to net earnings from classifying the shares held by physicians and management of The Specialty Alliance as a liability and increased contributions from the Pharmaceutical and Specialty Solutions segment and the growth businesses reported in Other [1].
Additionally, Cardinal Health plans to repurchase $750 million worth of shares and expects to spend approximately $600 million on capital expenditures during FY2026. The company also expects non-GAAP adjusted free cash flow to be between $2.75 billion and $3.25 billion for the year [1].
References:
[1] https://newsroom.cardinalhealth.com/2025-08-12-Cardinal-Health-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Results-and-Raises-Fiscal-Year-2026-Guidance

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios